In a significant move to bolster Africa’s public health research and innovation, the Africa Centres for Disease Control and Prevention (Africa CDC) and the Global Health European & Developing Countries Clinical Trials Partnership 3 (Global Health EDCTP3) have signed a Memorandum of Understanding (MoU). The agreement marks a renewed commitment to advancing scientific research, expanding clinical trials, and enhancing pandemic preparedness across the continent.
This partnership comes at a crucial time, as Africa faces growing health challenges fueled by climate change, geopolitical conflicts, and limited financial resources for public health initiatives. Building on a previous MoU signed in 2021 between Africa CDC and the EDCTP Association, the new agreement introduces a more structured and ambitious Joint Action Plan for 2025-2027, aimed at strengthening the continent’s ability to address pressing health concerns.
At the heart of this collaboration is the recognition that Africa must take the lead in shaping its healthcare future. The MoU outlines six key areas of cooperation, all designed to enhance Africa’s research capabilities, develop innovative medical solutions, and train the next generation of healthcare professionals. These areas include:
- Expanding Africa’s public health workforce through advanced training and capacity-building programs.
- Strengthening clinical trial ecosystems to support groundbreaking medical research.
- Driving innovation in vaccine, diagnostic, and treatment development for infectious diseases.
- Enhancing regulatory frameworks to streamline drug and vaccine approvals.
- Boosting local manufacturing to reduce Africa’s dependence on imported medical supplies.
- Fostering equitable partnerships to ensure that research benefits all African nations while contributing to global health security.
A central goal of the agreement is to increase Africa’s capacity to produce vaccines, therapeutics, and diagnostic tools locally, reducing the continent’s reliance on foreign manufacturers and improving access to life-saving medical interventions. By strengthening regulatory systems and investing in homegrown solutions, the MoU aims to position Africa as a leader in global health innovation.
Dr Michael Makanga, Executive Director of Global Health EDCTP3, emphasized the significance of this renewed collaboration, stating that after nearly a decade of partnership, this MoU lays a strong foundation for research, capacity-building, and equitable scientific advancements. Similarly, Dr Jean Kaseya, Director General of Africa CDC, highlighted the transformative potential of African-led health solutions, stressing that investing in local research and innovation is key to long-term health security.
By aligning strategic goals and pooling resources, Africa CDC and Global Health EDCTP3 are laying the groundwork for a more resilient, independent, and sustainable healthcare ecosystem—one that is equipped to tackle current and future public health challenges with African expertise and innovation.
Article by RB Correspodent
Photo/Google
Comment